Your browser doesn't support javascript.
loading
Nrf2 activation reprograms macrophage intermediary metabolism and suppresses the type I interferon response.
Ryan, Dylan G; Knatko, Elena V; Casey, Alva M; Hukelmann, Jens L; Dayalan Naidu, Sharadha; Brenes, Alejandro J; Ekkunagul, Thanapon; Baker, Christa; Higgins, Maureen; Tronci, Laura; Nikitopolou, Efterpi; Honda, Tadashi; Hartley, Richard C; O'Neill, Luke A J; Frezza, Christian; Lamond, Angus I; Abramov, Andrey Y; Arthur, J Simon C; Cantrell, Doreen A; Murphy, Michael P; Dinkova-Kostova, Albena T.
Afiliação
  • Ryan DG; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
  • Knatko EV; Medical Research Council Cancer Unit, University of Cambridge, Cambridge, UK.
  • Casey AM; Division of Cellular Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, James Arrott Drive, Dundee, Scotland, UK.
  • Hukelmann JL; Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.
  • Dayalan Naidu S; Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
  • Brenes AJ; Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
  • Ekkunagul T; Division of Cellular Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, James Arrott Drive, Dundee, Scotland, UK.
  • Baker C; Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
  • Higgins M; Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
  • Tronci L; Division of Cellular Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, James Arrott Drive, Dundee, Scotland, UK.
  • Nikitopolou E; Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
  • Honda T; Division of Cellular Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, James Arrott Drive, Dundee, Scotland, UK.
  • Hartley RC; Medical Research Council Cancer Unit, University of Cambridge, Cambridge, UK.
  • O'Neill LAJ; Medical Research Council Cancer Unit, University of Cambridge, Cambridge, UK.
  • Frezza C; Department of Chemistry and Institute of Chemical Biology & Drug Discovery, Stony Brook University, Stony Brook, NY, USA.
  • Lamond AI; School of Chemistry, University of Glasgow, Glasgow, UK.
  • Abramov AY; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
  • Arthur JSC; Medical Research Council Cancer Unit, University of Cambridge, Cambridge, UK.
  • Cantrell DA; Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
  • Murphy MP; Department of Clinical and Movement Neurosciences, University College London Queen Square Institute of Neurology, London, UK.
  • Dinkova-Kostova AT; Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
iScience ; 25(2): 103827, 2022 Feb 18.
Article em En | MEDLINE | ID: mdl-35198887

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article